MX350731B - Procesos para la preparacion de (s)-1-(3-etoxi-4-metoxifenil)-2-me tansulfoniletilamina. - Google Patents
Procesos para la preparacion de (s)-1-(3-etoxi-4-metoxifenil)-2-me tansulfoniletilamina.Info
- Publication number
- MX350731B MX350731B MX2016016157A MX2016016157A MX350731B MX 350731 B MX350731 B MX 350731B MX 2016016157 A MX2016016157 A MX 2016016157A MX 2016016157 A MX2016016157 A MX 2016016157A MX 350731 B MX350731 B MX 350731B
- Authority
- MX
- Mexico
- Prior art keywords
- ethoxy
- processes
- preparation
- methanesulfonylethylamine
- methoxyphenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/06—Sulfinamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Abstract
En el presente documento se proveen nuevos procesos para la preparación de intermediarios de aminosultona para la síntesis de 2-[1-(3-etoxi-4-metoxifenil)-2-metilsulfonil-etil]-4-acetilaminoi soindolino-1,3-diona, que es útil para prevenir o tratar enfermedades o condiciones relacionadas con un nivel o actividad anormalmente alto de TNF-a. Además, en el presente documento se proveen procesos para la producción comercial de (S)-1-(3-etoxi-4-metoxifenil)-2-metansulfonil-etilamina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261601226P | 2012-02-21 | 2012-02-21 | |
PCT/US2013/026780 WO2013126360A2 (en) | 2012-02-21 | 2013-02-20 | Processes for the preparation of (s)-1-(3-ethoxy-4methoxyphenyl)-2-methanesulfonylethylamine |
Publications (1)
Publication Number | Publication Date |
---|---|
MX350731B true MX350731B (es) | 2017-09-15 |
Family
ID=47755073
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014010002A MX344190B (es) | 2012-02-21 | 2013-02-20 | Procesos para la preparacion de (s) - 1 - (3 - etoxi - 4 - metoxifenil) - 2 - metansulfoniletilamina. |
MX2016016157A MX350731B (es) | 2012-02-21 | 2013-02-20 | Procesos para la preparacion de (s)-1-(3-etoxi-4-metoxifenil)-2-me tansulfoniletilamina. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014010002A MX344190B (es) | 2012-02-21 | 2013-02-20 | Procesos para la preparacion de (s) - 1 - (3 - etoxi - 4 - metoxifenil) - 2 - metansulfoniletilamina. |
Country Status (36)
Country | Link |
---|---|
US (3) | US9187417B2 (es) |
EP (4) | EP3378850B8 (es) |
JP (1) | JP2015509496A (es) |
KR (1) | KR101993248B1 (es) |
CN (3) | CN104245668B (es) |
AR (2) | AR090100A1 (es) |
AU (1) | AU2013203283B2 (es) |
BR (3) | BR122021020040B1 (es) |
CA (1) | CA2864517A1 (es) |
CO (1) | CO7061071A2 (es) |
CR (1) | CR20140395A (es) |
CY (2) | CY1121833T1 (es) |
DK (2) | DK3378850T3 (es) |
ES (3) | ES2675168T3 (es) |
HK (1) | HK1205501A1 (es) |
HR (2) | HRP20191249T1 (es) |
HU (2) | HUE048412T2 (es) |
IL (3) | IL234135A (es) |
IN (1) | IN2014DN06740A (es) |
LT (2) | LT3312156T (es) |
MX (2) | MX344190B (es) |
MY (1) | MY168296A (es) |
NI (1) | NI201400093A (es) |
NZ (1) | NZ628028A (es) |
PH (1) | PH12014501865A1 (es) |
PL (2) | PL3312156T3 (es) |
PT (2) | PT3312156T (es) |
RS (2) | RS59071B1 (es) |
RU (1) | RU2632875C2 (es) |
SG (1) | SG11201405035XA (es) |
SI (2) | SI3312156T1 (es) |
TR (1) | TR201910430T4 (es) |
TW (1) | TW201336815A (es) |
UA (1) | UA116773C2 (es) |
WO (1) | WO2013126360A2 (es) |
ZA (1) | ZA201405892B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9126906B2 (en) * | 2012-02-21 | 2015-09-08 | Celgene Corporation | Asymmetric synthetic processes for the preparation of aminosulfone compounds |
AR090100A1 (es) | 2012-02-21 | 2014-10-22 | Celgene Corp | Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina |
NZ628329A (en) | 2013-06-17 | 2017-12-22 | Celgene Corp | Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
IN2014MU01283A (es) | 2014-04-04 | 2015-10-09 | Cadila Healthcare Ltd | |
WO2015173792A1 (en) | 2014-05-11 | 2015-11-19 | Mapi Pharma Ltd. | Amorphous form of apremilast |
EP2949645A1 (en) | 2014-05-28 | 2015-12-02 | LEK Pharmaceuticals d.d. | Processes for the preparation of ß-aminosulfone compounds |
CN105622380B (zh) * | 2014-10-29 | 2020-06-30 | 南京安源生物医药科技有限公司 | 一种阿普斯特的制备方法及其中间体 |
CN104447445B (zh) * | 2014-12-05 | 2016-07-06 | 新发药业有限公司 | 一种合成阿普斯特中间体的制备方法 |
CN104744323B (zh) * | 2015-03-11 | 2016-08-31 | 中山奕安泰医药科技有限公司 | 一种阿普斯特手性胺中间体的合成工艺 |
CN104761474B (zh) * | 2015-03-11 | 2016-11-30 | 中山奕安泰医药科技有限公司 | 一种阿普斯特手性胺中间体的合成方法 |
CN104803897A (zh) * | 2015-04-23 | 2015-07-29 | 中山奕安泰医药科技有限公司 | 一种阿普斯特中间体的合成工艺 |
US10370329B2 (en) * | 2015-04-27 | 2019-08-06 | Mylan Laboratories Limited | Process for the enantiomeric resolution of apremilast intermediates |
US20180334429A1 (en) * | 2015-06-09 | 2018-11-22 | Dr. Reddy's Laboratories Limited | Process for preparation of apremilast and its intermediates |
EP3106457A1 (en) | 2015-06-15 | 2016-12-21 | LEK Pharmaceuticals d.d. | A novel synthetic pathway towards apremilast |
EP3144393A1 (en) * | 2015-09-18 | 2017-03-22 | LEK Pharmaceuticals d.d. | A synthetic pathway towards apremilast |
WO2017059040A1 (en) | 2015-09-29 | 2017-04-06 | Pliva Hrvatska D.O.O. | Processes for the preparation of apremilast and intermediates thereof |
US10399942B2 (en) | 2015-11-19 | 2019-09-03 | Alembic Pharmaceuticals Limited | Process and novel polymorphic form of Apremilast |
CN105461602B (zh) * | 2015-11-27 | 2018-01-02 | 东华大学 | 手性S或R‑3‑乙氧基‑4‑甲氧基‑α‑[(甲磺酰基)甲基]苯甲醇的制备方法 |
CN105330586B (zh) * | 2015-11-27 | 2017-12-22 | 东华大学 | 一种阿普斯特的制备方法 |
WO2017094031A2 (en) * | 2015-12-04 | 2017-06-08 | Sun Pharmaceutical Industries Limited | Novel process for preparation of apremilast |
CN106866475B (zh) * | 2015-12-11 | 2018-03-30 | 北大方正集团有限公司 | 一种阿普斯特中间体及其制备方法 |
US10774041B2 (en) | 2016-04-15 | 2020-09-15 | Davuluri Ramamohan Rao | Process for the preparation of apremilast |
US10196355B2 (en) | 2016-06-20 | 2019-02-05 | Johnson Matthey Public Limited Company | Forms of apremilast |
CN106543050B (zh) * | 2016-09-28 | 2018-04-10 | 中南大学湘雅医院 | 一种阿普斯特中间体的合成工艺 |
WO2018061034A1 (en) * | 2016-09-30 | 2018-04-05 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of 1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethanamine |
JP6684968B2 (ja) | 2016-11-10 | 2020-04-22 | エス・エム・エス・グループ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 連続鋳造圧延設備内において、金属的なストリップを製造するための方法 |
CN107445875A (zh) * | 2017-03-22 | 2017-12-08 | 陕西科技大学 | 一种用于制备阿普斯特的高纯度中间体的手性拆分方法 |
WO2018184933A1 (en) | 2017-04-04 | 2018-10-11 | Quimica Sintetica, S. A. | Racemic beta-aminosulfone compounds |
ES2829253T3 (es) | 2017-04-04 | 2021-05-31 | Quim Sintetica S A | Resolución de compuestos de beta-aminosulfona racémicos |
CN107966509B (zh) * | 2017-11-23 | 2020-06-23 | 中山奕安泰医药科技有限公司 | 一种(s)-1-(3-乙氧基-4-甲氧基苯基)-2-(甲基磺酰基)乙胺的检测方法 |
CN107827722B (zh) * | 2017-11-23 | 2021-02-19 | 中山奕安泰医药科技有限公司 | 一种3-乙氧基-4-甲氧基苯甲醛的合成方法 |
CN108008035B (zh) * | 2017-11-23 | 2020-07-07 | 中山奕安泰医药科技有限公司 | 3-乙氧基-4-甲氧基苯甲醛纯度的检测方法 |
CN107941945B (zh) * | 2017-11-23 | 2020-12-22 | 中山奕安泰医药科技有限公司 | 一种3-乙氧基-4-甲氧基苯甲腈的检测方法 |
CN107976501B (zh) * | 2017-11-23 | 2020-08-25 | 中山奕安泰医药科技有限公司 | 一种1-(3-乙氧基-4-甲氧基苯基)-2-(甲基磺酰基)乙胺的检测方法 |
CN108084066A (zh) * | 2017-12-12 | 2018-05-29 | 中山大学 | 一种阿普斯特及对映异构体的合成方法 |
JP6673614B1 (ja) * | 2018-10-16 | 2020-03-25 | 東芝エレベータ株式会社 | 防音装置 |
CN113896674B (zh) * | 2021-09-01 | 2023-10-27 | 深圳华中科技大学研究院 | 一种阿普斯特的合成方法 |
CN115850129B (zh) * | 2023-02-28 | 2023-05-16 | 凯莱英生命科学技术(天津)有限公司 | (s)-1-(3-乙氧基-4-甲氧基苯基)-2-(甲磺酰基)乙胺的制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878252A (en) * | 1970-09-24 | 1975-04-15 | Burroughs Wellcome Co | Ring substituted beta-hydroxy-phenyethylmethyl sulphone or sulphoxide |
GB1261455A (en) * | 1969-03-06 | 1972-01-26 | Burroughs Wellcome Co | Improvements in or relating to substituted acrylonitriles |
DE2051871A1 (en) * | 1969-05-16 | 1971-11-18 | The Wellcome Foundation Ltd., London | Beta-amino-alpha-aryloxymethylacrylonitrile - and 2,4-diamino-5-benzylpyrimidine derivs. useful as antibacterial agents |
KR20000064735A (ko) | 1996-03-22 | 2000-11-06 | 미리암 디. 메코너헤이, 블레어큐. 퍼거슨 | R-α-프로필-피페로닐 아민 및 그의 유사체의 신규 비대칭 합성 방법 |
US6020358A (en) * | 1998-10-30 | 2000-02-01 | Celgene Corporation | Substituted phenethylsulfones and method of reducing TNFα levels |
US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
JP5269281B2 (ja) | 2002-12-30 | 2013-08-21 | セルジーン コーポレイション | フルオロアルコキシ置換1,3−ジヒドロイソインドリル化合物およびそれらの医薬としての使用 |
US7208526B2 (en) | 2005-05-20 | 2007-04-24 | Hoffmann-La Roche Inc. | Styrylsulfonamides |
CA2711576C (en) * | 2008-01-25 | 2016-06-21 | High Point Pharmaceuticals, Llc | Tricyclic compounds as inhibitors of tnf-.alpha. synthesis and as pde4 inhibitors |
CN102209709B (zh) | 2008-09-10 | 2014-08-13 | 细胞基因公司 | 制备氨基砜化合物的方法 |
RS53357B (en) * | 2009-06-18 | 2014-10-31 | Concert Pharmaceuticals Inc. | ISOINDOLINE-1,3-DION DEUTERUM DERIVATIVES AS PDE4 AND TNF-ALPHA INHIBITORS |
RU2557236C2 (ru) | 2009-10-09 | 2015-07-20 | Селджин Корпорейшн | Способ получения соединений 2-(1-фенилэтил)изоиндолин-1-она |
WO2012097116A2 (en) | 2011-01-14 | 2012-07-19 | Celgene Corporation | Isotopologues of isoindole derivatives |
AR090100A1 (es) * | 2012-02-21 | 2014-10-22 | Celgene Corp | Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina |
US9126906B2 (en) * | 2012-02-21 | 2015-09-08 | Celgene Corporation | Asymmetric synthetic processes for the preparation of aminosulfone compounds |
-
2013
- 2013-02-19 AR ARP130100512A patent/AR090100A1/es active IP Right Grant
- 2013-02-20 WO PCT/US2013/026780 patent/WO2013126360A2/en active Application Filing
- 2013-02-20 ES ES13706898.7T patent/ES2675168T3/es active Active
- 2013-02-20 CN CN201380020005.4A patent/CN104245668B/zh active Active
- 2013-02-20 TW TW102105901A patent/TW201336815A/zh unknown
- 2013-02-20 KR KR1020147026186A patent/KR101993248B1/ko active IP Right Grant
- 2013-02-20 MX MX2014010002A patent/MX344190B/es active IP Right Grant
- 2013-02-20 LT LTEP17197504.8T patent/LT3312156T/lt unknown
- 2013-02-20 PT PT17197504T patent/PT3312156T/pt unknown
- 2013-02-20 AU AU2013203283A patent/AU2013203283B2/en active Active
- 2013-02-20 RS RS20190895A patent/RS59071B1/sr unknown
- 2013-02-20 PL PL17197504T patent/PL3312156T3/pl unknown
- 2013-02-20 ES ES17197504T patent/ES2735801T3/es active Active
- 2013-02-20 CA CA2864517A patent/CA2864517A1/en not_active Withdrawn
- 2013-02-20 MY MYPI2014702288A patent/MY168296A/en unknown
- 2013-02-20 HU HUE18168969A patent/HUE048412T2/hu unknown
- 2013-02-20 PT PT181689696T patent/PT3378850T/pt unknown
- 2013-02-20 BR BR122021020040-8A patent/BR122021020040B1/pt active IP Right Grant
- 2013-02-20 JP JP2014558783A patent/JP2015509496A/ja active Pending
- 2013-02-20 SG SG11201405035XA patent/SG11201405035XA/en unknown
- 2013-02-20 RS RS20200185A patent/RS60036B1/sr unknown
- 2013-02-20 LT LTEP18168969.6T patent/LT3378850T/lt unknown
- 2013-02-20 SI SI201331526T patent/SI3312156T1/sl unknown
- 2013-02-20 UA UAA201410289A patent/UA116773C2/uk unknown
- 2013-02-20 EP EP18168969.6A patent/EP3378850B8/en active Active
- 2013-02-20 ES ES18168969T patent/ES2773686T3/es active Active
- 2013-02-20 BR BR112014020444-6A patent/BR112014020444B1/pt active IP Right Grant
- 2013-02-20 CN CN202110092737.0A patent/CN112812044B/zh active Active
- 2013-02-20 HU HUE17197504 patent/HUE044192T2/hu unknown
- 2013-02-20 PL PL18168969T patent/PL3378850T3/pl unknown
- 2013-02-20 EP EP20150560.9A patent/EP3702347B1/en active Active
- 2013-02-20 IN IN6740DEN2014 patent/IN2014DN06740A/en unknown
- 2013-02-20 EP EP13706898.7A patent/EP2817288B1/en active Active
- 2013-02-20 MX MX2016016157A patent/MX350731B/es unknown
- 2013-02-20 SI SI201331685T patent/SI3378850T1/sl unknown
- 2013-02-20 RU RU2014138037A patent/RU2632875C2/ru active
- 2013-02-20 DK DK18168969.6T patent/DK3378850T3/da active
- 2013-02-20 EP EP17197504.8A patent/EP3312156B1/en active Active
- 2013-02-20 NZ NZ628028A patent/NZ628028A/en unknown
- 2013-02-20 DK DK17197504.8T patent/DK3312156T3/da active
- 2013-02-20 CN CN201710255841.0A patent/CN107033042A/zh active Pending
- 2013-02-20 BR BR122021020046-7A patent/BR122021020046B1/pt active IP Right Grant
- 2013-02-20 US US13/771,164 patent/US9187417B2/en active Active
- 2013-02-20 TR TR2019/10430T patent/TR201910430T4/tr unknown
-
2014
- 2014-08-12 ZA ZA2014/05892A patent/ZA201405892B/en unknown
- 2014-08-14 IL IL234135A patent/IL234135A/en active IP Right Grant
- 2014-08-18 PH PH12014501865A patent/PH12014501865A1/en unknown
- 2014-08-20 NI NI201400093A patent/NI201400093A/es unknown
- 2014-08-21 CR CR20140395A patent/CR20140395A/es unknown
- 2014-08-21 CO CO14183628A patent/CO7061071A2/es unknown
-
2015
- 2015-06-25 HK HK15106059.8A patent/HK1205501A1/xx unknown
- 2015-10-14 US US14/882,564 patent/US9586897B2/en active Active
-
2017
- 2017-01-25 US US15/414,782 patent/US9688623B2/en active Active
- 2017-05-23 IL IL252459A patent/IL252459B/en active IP Right Grant
-
2019
- 2019-07-11 CY CY20191100742T patent/CY1121833T1/el unknown
- 2019-07-12 HR HRP20191249TT patent/HRP20191249T1/hr unknown
-
2020
- 2020-01-10 AR ARP200100066A patent/AR117963A2/es unknown
- 2020-02-13 HR HRP20200245TT patent/HRP20200245T1/hr unknown
- 2020-02-21 CY CY20201100163T patent/CY1122799T1/el unknown
- 2020-03-04 IL IL273050A patent/IL273050A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX350731B (es) | Procesos para la preparacion de (s)-1-(3-etoxi-4-metoxifenil)-2-me tansulfoniletilamina. | |
CY1122795T1 (el) | Ινδαζολο-3-καρβοξαμιδια και η χρηση τους ως αναστολεις του σηματοδοτικου μονοπατιου wnt/b-κατενινης | |
MX2013009068A (es) | Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos. | |
MX2012003770A (es) | Metodos para la modulacion de autofagia a traves de la modulacion de productos de genes que aumentan la autofagia. | |
EA201891833A1 (ru) | Комбинация для лечения амиотрофического бокового склероза или родственных болезней | |
MY186267A (en) | Kinase inhibitor polymorphs | |
PH12014502513A1 (en) | Nampt inhibitors | |
NZ711896A (en) | Compounds and methods for kinase modulation, and indications therefor | |
MX2014013752A (es) | Inhibidores de nampt. | |
EA026892B9 (ru) | ТРИАЗОЛОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ mPGES-1 | |
EA201290644A1 (ru) | Блокаторы натриевых потенциал-зависимых каналов | |
UA113750C2 (xx) | Склад (+)-2-$1-(3-етокси-4-метоксифеніл)-2-метансульфонілетил]-4-ацетиламіноізоіндолін-1,3-діону | |
MX348311B (es) | Inhibidores nampt. | |
AU2011286276A8 (en) | Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases | |
EA201490423A1 (ru) | СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА | |
MX2013012652A (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12. | |
MX2013001906A (es) | Metodos para reducir la concentracion de lactato en la sangre. | |
CU20160083A7 (es) | Un proceso para preparar el compuesto (r)-1-((s)-2,2-dimetil-1,3-dioxolan-4-il)etanol y sus productos intermediarios | |
MX2014013758A (es) | Derivados de tiazolcarboxamida para usarse como inhibidores de nampt. | |
CR11631A (es) | Paramyxovirus eficaz como antitumoral | |
EA201492169A1 (ru) | Новые соединения | |
EA201001362A1 (ru) | Хинолины в качестве ингибиторов фарнезилпирофосфатсинтазы | |
EA033160B1 (ru) | Соединения для лечения заболеваний, связанных с ишемией-реперфузией | |
MX2014004853A (es) | 1-cicloalquil- o 1-heterociclil-hidroxiimino-3-fenil-propanos. | |
AR118704A2 (es) | Polipéptido del factor vii para tratar enfermedades |